Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System
The instrument, the first benchtop-scale platform in Asahi Kasei Bioprocess’s VANTIJ family, extends the automation and operator-focused design principles of the existing portfolio while simplifying virus filtration processes. The post Asahi Kasei Introduces VANTIJ ® SU-VFC Benchtop Virus-Filtration System appeared first on GEN - Genetic Engineering and Biotechnology News .
Asahi Kasei Bioprocess will introduce its VANTIJ® SU-VFC benchtop virus-filtration system at the Bioprocess International (BPI) East event in Boston. The compact system is designed for laboratory-scale and process development applications, offering automated, single-use virus filtration. It is the first benchtop-scale platform in Asahi Kasei Bioprocess’s VANTIJ family, extending the automation and operator-focused design of existing products.
The VANTIJ can accommodate workflows using 0.12 m² or 0.3 m² Planova 35N virus-removal filters. Its design simplifies small-scale Planova virus filtration while maintaining process control and data capabilities. The system is targeted at gene therapy manufacturing, addressing operational complexities like long production timelines, regulatory requirements, operator training, and therapy-specific needs.
It features guided setup, tool-free tube installation, intuitive connections, and recipe-driven software, enabling batch reporting and supporting filtration processes. Chris Rombach, president of Asahi Kasei Bioprocess America, emphasizes the company's commitment to supporting manufacturers in pursuing efficient pathways for bringing therapies to patients.
The VANTIJ SU-VFC Benchtop reflects this commitment, simplifying critical process steps for the pharmaceutical and bioprocessing industries.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
